Verona Pharma Plc Stock Price History
| VRNA Stock | USD 39.63 0.27 0.68% |
Below is the normalized historical share price chart for Verona Pharma PLC extending back to April 27, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Verona Pharma stands at 39.63, as last reported on the 1st of December, with the highest price reaching 40.76 and the lowest price hitting 39.59 during the day.
If you're considering investing in Verona Stock, it is important to understand the factors that can impact its price. Verona Pharma appears to be very steady, given 3 months investment horizon. Verona Pharma PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.22, which indicates the firm had a 0.22% return per unit of risk over the last 3 months. By inspecting Verona Pharma's technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please review Verona Pharma's Semi Deviation of 1.76, risk adjusted performance of 0.1699, and Coefficient Of Variation of 470.51 to confirm if our risk estimates are consistent with your expectations.
At present, Verona Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 323.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 75.3 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.63, whereas Price To Sales Ratio is forecasted to decline to 4,122. Verona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of April 2017 | 200 Day MA 22.4458 | 50 Day MA 34.2499 | Beta 0.424 |
Verona |
Sharpe Ratio = 0.2173
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VRNA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Verona Pharma is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verona Pharma by adding it to a well-diversified portfolio.
Price Book 24.8521 | Enterprise Value Ebitda (20.89) | Price Sales 576.6306 | Shares Float 392.2 M | Wall Street Target Price 46.5714 |
Verona Pharma Stock Price History Chart
There are several ways to analyze Verona Stock price data. The simplest method is using a basic Verona candlestick price chart, which shows Verona Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 27, 2024 | 39.9 |
| Lowest Price | September 6, 2024 | 26.39 |
Verona Pharma December 1, 2024 Stock Price Synopsis
Various analyses of Verona Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Verona Stock. It can be used to describe the percentage change in the price of Verona Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Verona Stock.| Verona Pharma Price Rate Of Daily Change | 0.99 | |
| Verona Pharma Price Action Indicator | (0.68) | |
| Verona Pharma Price Daily Balance Of Power | (0.23) |
Verona Pharma December 1, 2024 Stock Price Analysis
Verona Stock Price History Data
The price series of Verona Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 13.89 with a coefficient of variation of 12.69. The daily prices for the period are distributed with arithmetic mean of 32.95. The median price for the last 90 days is 33.67.| Open | High | Low | Close | Volume | ||
12/01/2024 | 40.60 | 40.76 | 39.59 | 39.63 | ||
| 11/29/2024 | 40.60 | 40.76 | 39.59 | 39.63 | 475,159 | |
| 11/27/2024 | 40.00 | 40.00 | 39.21 | 39.90 | 654,147 | |
| 11/26/2024 | 39.80 | 40.00 | 39.10 | 39.84 | 930,124 | |
| 11/25/2024 | 39.30 | 40.00 | 38.90 | 39.68 | 1,109,518 | |
| 11/22/2024 | 38.11 | 39.25 | 37.67 | 38.81 | 740,727 | |
| 11/21/2024 | 39.58 | 39.58 | 37.86 | 37.86 | 794,309 | |
| 11/20/2024 | 38.00 | 39.33 | 37.61 | 38.85 | 1,155,655 | |
| 11/19/2024 | 35.49 | 38.30 | 35.00 | 38.09 | 1,406,196 | |
| 11/18/2024 | 35.52 | 36.08 | 34.51 | 34.94 | 887,615 | |
| 11/15/2024 | 35.01 | 35.97 | 34.71 | 35.66 | 978,520 | |
| 11/14/2024 | 36.75 | 37.07 | 34.95 | 35.37 | 915,101 | |
| 11/13/2024 | 39.00 | 39.50 | 36.85 | 36.93 | 822,864 | |
| 11/12/2024 | 39.35 | 40.03 | 38.78 | 39.00 | 1,603,944 | |
| 11/11/2024 | 38.95 | 40.02 | 38.73 | 39.87 | 1,477,085 | |
| 11/08/2024 | 38.50 | 38.87 | 37.52 | 38.58 | 1,195,600 | |
| 11/07/2024 | 37.54 | 38.24 | 36.49 | 38.18 | 614,731 | |
| 11/06/2024 | 38.39 | 38.52 | 36.74 | 37.59 | 1,018,606 | |
| 11/05/2024 | 39.05 | 39.40 | 37.80 | 38.39 | 1,208,824 | |
| 11/04/2024 | 33.00 | 39.38 | 31.60 | 38.15 | 3,304,405 | |
| 11/01/2024 | 34.42 | 35.09 | 34.03 | 34.98 | 884,139 | |
| 10/31/2024 | 34.00 | 34.31 | 33.31 | 33.93 | 615,333 | |
| 10/30/2024 | 33.09 | 34.77 | 33.09 | 34.19 | 1,369,023 | |
| 10/29/2024 | 33.02 | 33.86 | 32.90 | 33.67 | 418,384 | |
| 10/28/2024 | 34.00 | 34.25 | 33.03 | 33.11 | 549,266 | |
| 10/25/2024 | 34.40 | 35.08 | 33.57 | 33.86 | 771,234 | |
| 10/24/2024 | 34.87 | 35.21 | 34.38 | 34.43 | 604,209 | |
| 10/23/2024 | 34.53 | 35.05 | 34.32 | 34.93 | 792,481 | |
| 10/22/2024 | 34.53 | 35.62 | 34.23 | 34.87 | 1,073,733 | |
| 10/21/2024 | 34.56 | 35.25 | 34.25 | 34.97 | 1,194,246 | |
| 10/18/2024 | 34.65 | 35.28 | 34.33 | 34.63 | 986,306 | |
| 10/17/2024 | 33.97 | 34.72 | 33.67 | 34.66 | 740,542 | |
| 10/16/2024 | 34.07 | 34.41 | 33.29 | 34.03 | 525,392 | |
| 10/15/2024 | 34.15 | 34.74 | 33.40 | 34.07 | 759,310 | |
| 10/14/2024 | 32.61 | 34.69 | 32.50 | 34.26 | 1,584,258 | |
| 10/11/2024 | 31.37 | 32.96 | 31.12 | 32.67 | 1,061,900 | |
| 10/10/2024 | 31.48 | 32.20 | 31.12 | 31.37 | 536,857 | |
| 10/09/2024 | 32.12 | 32.12 | 31.09 | 31.75 | 649,419 | |
| 10/08/2024 | 32.00 | 32.52 | 31.37 | 31.77 | 1,330,410 | |
| 10/07/2024 | 32.17 | 32.81 | 31.44 | 32.05 | 1,015,524 | |
| 10/04/2024 | 30.81 | 32.88 | 30.76 | 32.01 | 1,173,083 | |
| 10/03/2024 | 29.30 | 31.83 | 29.30 | 30.81 | 1,871,538 | |
| 10/02/2024 | 28.69 | 29.34 | 28.46 | 28.71 | 443,432 | |
| 10/01/2024 | 28.95 | 29.18 | 28.30 | 28.99 | 597,299 | |
| 09/30/2024 | 28.60 | 29.40 | 28.36 | 28.77 | 809,486 | |
| 09/27/2024 | 27.70 | 29.11 | 27.54 | 28.76 | 937,165 | |
| 09/26/2024 | 28.56 | 28.71 | 27.62 | 27.64 | 510,471 | |
| 09/25/2024 | 29.61 | 29.96 | 27.75 | 28.26 | 910,376 | |
| 09/24/2024 | 29.68 | 29.99 | 29.11 | 29.66 | 794,661 | |
| 09/23/2024 | 30.32 | 30.46 | 28.85 | 29.60 | 812,689 | |
| 09/20/2024 | 29.47 | 30.30 | 29.39 | 29.99 | 545,526 | |
| 09/19/2024 | 29.85 | 30.09 | 29.14 | 29.40 | 487,813 | |
| 09/18/2024 | 29.19 | 30.50 | 28.91 | 29.23 | 506,718 | |
| 09/17/2024 | 30.54 | 30.54 | 28.78 | 29.19 | 470,027 | |
| 09/16/2024 | 29.82 | 30.54 | 29.82 | 30.16 | 668,471 | |
| 09/13/2024 | 30.15 | 30.54 | 29.30 | 29.78 | 864,106 | |
| 09/12/2024 | 30.13 | 30.73 | 29.65 | 29.99 | 1,217,260 | |
| 09/11/2024 | 28.00 | 30.45 | 27.92 | 30.15 | 2,993,433 | |
| 09/10/2024 | 27.53 | 28.24 | 26.90 | 28.04 | 733,855 | |
| 09/09/2024 | 26.72 | 27.77 | 25.79 | 27.49 | 836,300 | |
| 09/06/2024 | 27.04 | 27.39 | 25.54 | 26.39 | 1,466,500 |
About Verona Pharma Stock history
Verona Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verona Pharma PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verona Pharma stock prices may prove useful in developing a viable investing in Verona Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.3 M | 75.3 M | |
| Net Loss | -61.8 M | -58.7 M |
Verona Pharma Quarterly Net Working Capital |
|
Verona Pharma Stock Technical Analysis
Verona Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Verona Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verona Pharma's price direction in advance. Along with the technical and fundamental analysis of Verona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1699 | |||
| Jensen Alpha | 0.5798 | |||
| Total Risk Alpha | 0.1253 | |||
| Sortino Ratio | 0.2199 | |||
| Treynor Ratio | 1.94 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |